Can adopting AI tools unlock a new era of open science?
Discover how generative AI tools can lower the burden of data sharing, enhancing open science.
A central online news resource for professionals involved in the development of medical publications and involved in publication planning and medical writing.
Discover how generative AI tools can lower the burden of data sharing, enhancing open science.
Read about a new tool designed to improve the clarity of infographics and visual abstracts in comparative health research.
Get up to speed on why the general public struggle to understand preprint status.
Discover how publishers are developing AI tools to improve peer review and streamline publishing workflows.
Discover the RIGHT-COI&F checklist, developed to improve conflict of interest and funding reporting in healthcare guidelines.
Find out how publisher AI policies need to evolve in the face of fast-changing technology.
Plans for a strategic 3-year partnership between the EQUATOR Network and Centre for Open Science.
Find out more about a new AI service to detect fake manuscripts.
Read about a new checklist developed to facilitate transparent reporting of consensus methods.
Find out what happened in the year since eLife ended accept/reject decisions in favour of ‘reviewed preprints’.
Crafting or updating an AI policy? Stay up to speed with the latest recommendations from the Healthcare Communications Association.
Find out about the National Association of Science Writers’ (NASW) position on the use of AI and maintaining integrity and accuracy in scientific reporting.
As some aspects of the open science movement gain ground, recent data from UNESCO show a mixed outlook regarding its global impact.
Read about the first nationwide investigation into academic research retractions in China, and how it could be used to help monitor research integrity.
Find out how the LATITUDES Network could help improve validity assessment during evidence synthesis.
Read about practical advice for trial sponsors on reporting clinical trials while protecting confidential information.